Yuki Teramoto

887 total citations
59 papers, 389 citations indexed

About

Yuki Teramoto is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, Yuki Teramoto has authored 59 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 29 papers in Surgery and 11 papers in Rheumatology. Recurrent topics in Yuki Teramoto's work include Prostate Cancer Treatment and Research (24 papers), Bladder and Urothelial Cancer Treatments (17 papers) and Prostate Cancer Diagnosis and Treatment (14 papers). Yuki Teramoto is often cited by papers focused on Prostate Cancer Treatment and Research (24 papers), Bladder and Urothelial Cancer Treatments (17 papers) and Prostate Cancer Diagnosis and Treatment (14 papers). Yuki Teramoto collaborates with scholars based in Japan, United States and India. Yuki Teramoto's co-authors include Hiroshi Miyamoto, Guiyang Jiang, Takashi Kobayashi, Osamu Ogawa, Takahiro Inoue, Shusuke Akamatsu, Taichi Mizushima, Toshinari Yamasaki, George J. Netto and Alexander S. Baras and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and International Journal of Molecular Sciences.

In The Last Decade

Yuki Teramoto

54 papers receiving 385 citations

Peers

Countries citing papers authored by Yuki Teramoto

Since Specialization

Citations

This map shows the geographic impact of Yuki Teramoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Teramoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Teramoto more than expected).

Fields of papers citing papers by Yuki Teramoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Teramoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Teramoto. The network helps show where Yuki Teramoto may publish in the future.

Co-authorship network of co-authors of Yuki Teramoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Teramoto. A scholar is included among the top collaborators of Yuki Teramoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Teramoto. Yuki Teramoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unusual Pancreatic Metastasis of Solid Subtype Adenoid Cystic Carcinoma: Reappraisal of MYB and CD117 Immunostaining Utility in Liquid‐Based Cytology 2025 ·Cytopathology ·(unknown), Yuki Teramoto, (unknown), Masahiro Hirata, Hironori Haga	1
2	Mediastinoscopy-Assisted Esophagectomy as an Effective Treatment for IgG4-Related Esophageal Stenosis: A Case Report 2025 ·Surgical Case Reports ·Masazumi Sakaguchi, Shigeru Tsunoda, (unknown), Yuki Teramoto, Shintaro Okumura, Masahiro Hara, (unknown), (unknown), (unknown), Yu Yoshida, Takehito Yamamoto, Takashi Sakamoto, Masahiro Maeda, Keiko Kasahara, Ryosuke Okamura, Nobuaki Hoshino, Yoshiro Itatani, (unknown), (unknown), Kazutaka Obama	0
3	Immunohistochemistry scoring for human epidermal growth factor receptor 2 can be used to predict pathological response to cisplatin-based neoadjuvant chemotherapy in a subset of immunohistochemically subtyped muscle-invasive bladder cancer 2025 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·(unknown), Yuki Teramoto, Hironori Haga	1
4	MP65-14 THE IMPACT OF GULP1 AS A DOWNSTREAM EFFECTOR OF THE ESTROGEN RECEPTOR-β ON MODULATING CISPLATIN SENSITIVITY IN BLADDER CANCER 2024 ·The Journal of Urology ·Tomoyuki Tatenuma, (unknown), Mohammad Amin Elahi Najafi, (unknown), Yuki Teramoto, Hiroshi Miyamoto	1
5	Prostate Cancer Risk Stratification by Simple Scoring of the Current pT3 Lesions: A Proposal for a New Pathologic T-Staging System 2024 ·Modern Pathology ·Hiroshi Miyamoto, Yuki Teramoto, (unknown), Ying Wang, Jean Joseph	2
6	Latrophilin-3 as a downstream effector of the androgen receptor induces bladder cancer progression 2024 ·Discover Oncology ·(unknown), Yuki Teramoto, (unknown), Hiroshi Miyamoto	1
7	Cribriform intraductal carcinoma of the prostate may be more aggressive than cribriform conventional/acinar prostatic adenocarcinoma 2024 ·Pathology ·(unknown), Yuki Teramoto, Hiroshi Miyamoto	1
8	GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer 2023 ·International Journal of Molecular Sciences ·Mohammad Amin Elahi Najafi, (unknown), Yuki Teramoto, Tomoyuki Tatenuma, Guiyang Jiang, Hiroshi Miyamoto	6
9	Comedonecrosis within conventional prostatic adenocarcinoma vs. intraductal carcinoma of the prostate: their clinical significance is not comparable 2023 ·Human Pathology ·(unknown), Yuki Teramoto, Hiroshi Miyamoto	1
10	Circularity of islets is a distinct marker for the pathological diagnosis of adult non-neoplastic hyperinsulinemic hypoglycemia using surgical specimens 2023 ·Diagnostic Pathology ·(unknown), Sachiko Minamiguchi, Tatsuki R. Kataoka, Junji Fujikura, Toshihiko Masui, Masakazu Fujimoto, Yosuke Yamada, Yasuhide Takeuchi, Yuki Teramoto, (unknown), (unknown), (unknown), S. Otsuki, (unknown), Hironori Haga	1
11	Clinical significance of perineural invasion by prostate cancer on magnetic resonance imaging–targeted biopsy 2022 ·Human Pathology ·(unknown), Yuki Teramoto, (unknown), Ying Wang, Hiroshi Miyamoto	9
12	Radical prostatectomy findings and oncologic outcomes in patients with prostate cancer detected on systematic sextant biopsy only, MRI-targeted biopsy only, or both 2022 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Yuki Teramoto, Ying Wang, Hiroshi Miyamoto	3
13	Prognostic significance of cribriform adenocarcinoma of the lung: validation analysis of 1,057 Japanese patients with resected lung adenocarcinoma and a review of the literature 2021 ·Translational Lung Cancer Research ·Naoki Nakajima, Akihiko Yoshizawa, (unknown), (unknown), Yuki Teramoto, Shinji Sumiyoshi, Kyoko Kondo, Makoto Sonobe, Masatsugu Hamaji, Toshi Menju, Hiroshi Date, Hironori Haga	12
14	Divergent Nematic Susceptibility near the Pseudogap Critical Point in a Cuprate Superconductor 2020 ·Journal of the Physical Society of Japan ·Kousuke Ishida, S. Hosoi, Yuki Teramoto, Tomohiro Usui, Yuta Mizukami, Kenji Itaka, Yuji Matsuda, Takao Watanabe, T. Shibauchi	33
15	5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence 2020 ·Bladder Cancer ·(unknown), (unknown), Guiyang Jiang, Yuki Teramoto, Hiroshi Miyamoto	4
16	Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies 2019 ·British Journal of Cancer ·Yuki Kita, (unknown), Ryoichi Saito, Yuki Teramoto, Ryusuke Tanaka, (unknown), Kenji Nakayama, (unknown), (unknown), Shusuke Akamatsu, Toshinari Yamasaki, Takahiro Inoue, Yasuhiko Tabata, Yasushi Okuno, Osamu Ogawa, Takashi Kobayashi	53
17	Detectability of prostate cancer in different parts of the gland with 3-Tesla multiparametric magnetic resonance imaging: correlation with whole-mount histopathology 2019 ·International Journal of Clinical Oncology ·Katsuhiro Ito, Akihiro Furuta, Aki Kido, Yuki Teramoto, Shusuke Akamatsu, Naoki Terada, Toshinari Yamasaki, Takahiro Inoue, Osamu Ogawa, Takashi Kobayashi	7
18	Diameter of the dilated main pulmonary artery in patients with pulmonary hypertension decreases after lung transplantation 2019 ·Surgery Today ·Hidenao Kayawake, Akihiro Aoyama, Hideyuki Kinoshita, (unknown), Shiro Baba, Yuki Teramoto, Aya Miyagawa‐Hayashino, Kazuhiro Yamazaki, Hideki Motoyama, Masatsugu Hamaji, Daisuke Nakajima, Toyofumi F. Chen‐Yoshikawa, Hiroshi Date	2
19	Duodenal obstruction induced by retroperitoneal progression of bladder cancer: a report of two cases 2019 ·Abdominal Radiology ·Koji Tokunaga, Akihiro Furuta, Shigeki Arizono, Yuki Teramoto, Hiromitsu Negoro, Aki Kido, Hiroyoshi Isoda, Kaori Togashi	1
20	Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report 2018 ·Diagnostic Pathology ·(unknown), Yuki Togashi, Satoko Baba, Yo Kaku, Yuki Teramoto, Takaki Sakurai, Hironori Haga, Kengo Takeuchi	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact